Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A Phase 1/2, Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of the Lower Dose of Bortezomib Plus Busulfan and Melphalan As a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: Result of Phase 1 Trial
- Issue Date
- 16-Nov-2012
- Publisher
- AMER SOC HEMATOLOGY
- Citation
- BLOOD, v.120, no.21
- Journal Title
- BLOOD
- Volume
- 120
- Number
- 21
- ISSN
- 0006-4971
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Lee, Jae Hoon
- College of Medicine (Department of Medicine)